Skye Bioscience SKYE
NASDAQ SKYE
$0.28 -0.03 (-9.68%)
At close: Aug 20, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Operating Margin Growth (1y) (2014)

Skye Bioscience (SKYE) Operating Margin Growth (1y) (2014) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 78.00
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1,135.00
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 7,666.00
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1,238.00
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 2,002.00
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 29,091.00
8 Royalty Pharma 26.98 Bn 26.14 Bn - -1,651.00
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -3,558.00
10 Skye Bioscience 11.17 Mn 11.17 Mn - -

Historic Data

Download Data
DateValue
Apr 30, 2014 -1,416.00